One A Day Men's 50+ Advantage ads say selenium may cut men's risk of prostate cancer, a consumer group says.
The emerging science hasn't compelled us to change our claims, and the FDA claim is intact."
In its promotions, the company says "emerging research" suggests that selenium might reduce the risk of prostate cancer, the center said.
"It's astounding that a company such as Bayer ... would make such deceptive claims," the center's litigation director, Steve Gardner, told reporters during the same teleconference.
The Selenium and Vitamin E Cancer Prevention Trial involving 35,000 U.S. and Canadian men was halted in October when researchers determined that selenium was not protecting the men from prostate cancer and may have been causing diabetes in some of them.